These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32949598)

  • 1. Update of treatment for mucopolysaccharidosis type III (sanfilippo syndrome).
    Kong W; Yao Y; Zhang J; Lu C; Ding Y; Meng Y
    Eur J Pharmacol; 2020 Dec; 888():173562. PubMed ID: 32949598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucopolysaccharidosis type III (Sanfilippo Syndrome): emerging treatment strategies.
    de Ruijter J; Valstar MJ; Wijburg FA
    Curr Pharm Biotechnol; 2011 Jun; 12(6):923-30. PubMed ID: 21235449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapies for mucopolysaccharidosis type III.
    Seker Yilmaz B; Davison J; Jones SA; Baruteau J
    J Inherit Metab Dis; 2021 Jan; 44(1):129-147. PubMed ID: 32944950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucopolysaccharidosis III (Sanfilippo Syndrome)- disease presentation and experimental therapies.
    Gilkes JA; Heldermon CD
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():133-40. PubMed ID: 25345095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosaminoglycans and mucopolysaccharidosis type III.
    Jakobkiewicz-Banecka J; Gabig-Ciminska M; Kloska A; Malinowska M; Piotrowska E; Banecka-Majkutewicz Z; Banecki B; Wegrzyn A; Wegrzyn G
    Front Biosci (Landmark Ed); 2016 Jun; 21(7):1393-409. PubMed ID: 27100513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration.
    Lau AA; Hemsley KM
    J Mol Med (Berl); 2017 Oct; 95(10):1043-1052. PubMed ID: 28660346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches.
    Benetó N; Vilageliu L; Grinberg D; Canals I
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management.
    Sawamoto K; Álvarez González JV; Piechnik M; Otero FJ; Couce ML; Suzuki Y; Tomatsu S
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel missense mutation in lysosomal sulfamidase is the basis of MPS III A in a spontaneous mouse mutant.
    Bhattacharyya R; Gliddon B; Beccari T; Hopwood JJ; Stanley P
    Glycobiology; 2001 Jan; 11(1):99-103. PubMed ID: 11181566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sanfilippo syndrome: a mini-review.
    Valstar MJ; Ruijter GJ; van Diggelen OP; Poorthuis BJ; Wijburg FA
    J Inherit Metab Dis; 2008 Apr; 31(2):240-52. PubMed ID: 18392742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Hurler and Sanfilippo syndrome in a sibling pair.
    Sun A; Hopwood JJ; Thompson J; Cederbaum SD
    Mol Genet Metab; 2011 Jun; 103(2):135-7. PubMed ID: 21393040
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Marcó S; Haurigot V; Bosch F
    Hum Gene Ther; 2019 Oct; 30(10):1211-1221. PubMed ID: 31482754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III.
    Ghosh A; Shapiro E; Rust S; Delaney K; Parker S; Shaywitz AJ; Morte A; Bubb G; Cleary M; Bo T; Lavery C; Bigger BW; Jones SA
    Orphanet J Rare Dis; 2017 Jun; 12(1):117. PubMed ID: 28651568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease.
    Dziedzic D; Wegrzyn G; Jakóbkiewicz-Banecka J
    Eur J Hum Genet; 2010 Feb; 18(2):200-5. PubMed ID: 19690584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome.
    Scott HS; Blanch L; Guo XH; Freeman C; Orsborn A; Baker E; Sutherland GR; Morris CP; Hopwood JJ
    Nat Genet; 1995 Dec; 11(4):465-7. PubMed ID: 7493035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous administration of human umbilical cord blood cells in an animal model of MPS III B.
    Garbuzova-Davis S; Klasko SK; Sanberg PR
    J Comp Neurol; 2009 Jul; 515(1):93-101. PubMed ID: 19399896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of neurocognition in MPS disorders: A review.
    Shapiro EG; Eisengart JB
    Mol Genet Metab; 2021 May; 133(1):8-34. PubMed ID: 33741271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucopolysaccharidosis type IIIB: characterisation and expression of wild-type and mutant recombinant alpha-N-acetylglucosaminidase and relationship with sanfilippo phenotype in an attenuated patient.
    Yogalingam G; Weber B; Meehan J; Rogers J; Hopwood JJ
    Biochim Biophys Acta; 2000 Nov; 1502(3):415-25. PubMed ID: 11068184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings.
    Yamazaki N; Kosuga M; Kida K; Takei G; Fukuhara Y; Matsumoto H; Senda M; Honda A; Ishiguro A; Koike T; Yabe H; Okuyama T
    Brain Dev; 2019 Jun; 41(6):546-550. PubMed ID: 30755342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term enzyme replacement in the murine model of Sanfilippo syndrome type B.
    Yu WH; Zhao KW; Ryazantsev S; Rozengurt N; Neufeld EF
    Mol Genet Metab; 2000 Dec; 71(4):573-80. PubMed ID: 11136549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.